Asset Details
Do you wish to reserve the book?
Exploring sex differences in myocardial fibrosis in patients with structurally normal hearts
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Exploring sex differences in myocardial fibrosis in patients with structurally normal hearts
Do you wish to request the book?
Exploring sex differences in myocardial fibrosis in patients with structurally normal hearts
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Exploring sex differences in myocardial fibrosis in patients with structurally normal hearts
2025
Overview
Myocardial fibrosis as evaluated by cardiovascular magnetic resonance (CMR) plays a central role in pathophysiology of cardiovascular diseases and exhibits sex-specific differences. The goal of our study was to assess sex-related differences in fibrosis in patients with structurally normal hearts. We retrospectively studied patients undergoing clinical CMR at 1.5T with preserved cardiac function and no structural abnormalities. Standardized CMR protocols included cine imaging, T1 mapping, and late gadolinium enhancement (LGE) imaging. LGE presence, extent, and pattern, and extracellular volume fraction (ECV) were evaluated according to sex. The primary outcomes were all cause mortality and new-onset heart failure. Of 525 patients studied (43.1 ± 14.2 years, 69.5% female), 258 (49.1%) exhibited nonischemic LGE. Nonischemic LGE was more common in males (61.3% vs. 43.8%,
p
< 0.001), and remained so in multivariable analysis after adjustment for clinical covariates (OR 2.2, CI 1.17–4.13,
p
= 0.015). Women had higher ECV values (26.5 ± 4.3% vs. 23.2 ± 3.7,
p
< 0.001), and these sex differences remained significant in multivariable analysis (β coefficient = 1.29,
p
= 0.02). During 5.8 years follow-up there was no association between primary outcomes and nonischemic LGE. There was a trend towards association between ECV increase and all-cause mortality. The optimal ECV cutoff for all-cause mortality was 31.3% for females and 27.5% for males. Among patients with structurally normal hearts with preserved systolic function referred for clinical CMR exams, nonischemic LGE is more frequently observed in males, whereas ECV values are higher in females. ECV increase may be associated with all-cause mortality, both in female and male cohorts.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Adult
/ Cardiomyopathies - diagnostic imaging
/ Cardiomyopathies - pathology
/ Cardiovascular magnetic resonance imaging
/ Extracellular volume fraction
/ Female
/ Females
/ Fibrosis
/ Heart
/ Humanities and Social Sciences
/ Humans
/ Late gadolinium enhancement imaging
/ Magnetic Resonance Imaging, Cine
/ Male
/ Males
/ Patients
/ Science
/ Software
